Skip to main content
Clinical Trials/NCT03536988
NCT03536988
Unknown
Not Applicable

Transanal Versus Transabdominal Minimally Invasive Proctectomy With Ileal Pouch-annal Anastomosis On Postoperative Outcomes in Ulcerative Colitis: a Randomized Controlled Trial

Jinling Hospital, China1 site in 1 country84 target enrollmentApril 12, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ulcerative Colitis
Sponsor
Jinling Hospital, China
Enrollment
84
Locations
1
Primary Endpoint
Postoperative Complications
Last Updated
7 years ago

Overview

Brief Summary

The objective of this RCT is to compare the postoperative outcome of transanal versus transabdominal minimally invasive proctectomy with ileal pouch-annal anastomosis in patients with ulcerative colitis.

Detailed Description

Theoritically, the advantge of TAMIS surgery over traditional trans-abdominal IPAA surgery incudes shorter operation time due to simulatous surgery transanlly and transabdominally, reduced operative difficulty in narrow male pelvis, less retained rectal cuff and less "dog-ear" formation. However, its adgange has not been proven in prospecitve randomized trials. The aim of current study is to compare the short and long-term postoperative outcome of transanal versus transabdominal minimally invasive proctectomy with ileal pouch-annal anastomosis in patients with ulcerative colitis.

Registry
clinicaltrials.gov
Start Date
April 12, 2018
End Date
December 1, 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Jinling Hospital, China
Responsible Party
Principal Investigator
Principal Investigator

Jianfeng Gong

associate professor

Jinling Hospital, China

Eligibility Criteria

Inclusion Criteria

  • Clincially and pathologically proven ulcerative colitis
  • Aged 18-75 years
  • Patients who will undergo proctectomy and IPAA surgery, incuding the first stage of two-stage surgery, or the second stage of three-stage or modified two-stage surgery
  • Elective surgery
  • Informed constent obtained.

Exclusion Criteria

  • A contraindication for minimally invasive surgery or TAMIS surgery
  • Ileus or peritonitis
  • Previous surgery in rectum
  • Pregnancy
  • Carcinogenesis of rectum, dysplasia or stricture of ATZ, or planned mucosectomy
  • Patients with planned permnant ileostomy

Outcomes

Primary Outcomes

Postoperative Complications

Time Frame: Day 30

Postoperative complcations were documented using comprehensive complication index(CCI)

Secondary Outcomes

  • Postoperative quality of life(up to 1 year)
  • Intraoperative complications(24 Hr)
  • Time to GI-2 recovery(Day 90)
  • The incidence of cuffitis and pouchitis(up to 1 year)
  • The incidence of pouch extension(24 Hr)
  • Postoperative anastmotic leakage(Day 90)
  • Overall cost of treatment(up to 1 year)
  • Remaining length of anal mucosa.(24 Hr)
  • Estimated blood loss(24 Hr)
  • Postoperative length of hospital stay(Day 90)
  • Duration of operation(24 Hr)

Study Sites (1)

Loading locations...

Similar Trials